Defective Lymphoid Development in Mice Lacking Jak3
- 3 November 1995
- journal article
- other
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 270 (5237) , 800-802
- https://doi.org/10.1126/science.270.5237.800
Abstract
The Janus tyrosine kinases (Jaks) play a central role in signaling through cytokine receptors. Although Jak1, Jak2, and Tyk2 are widely expressed, Jak3 is predominantly expressed in hematopoietic cells and is known to associate only with the common γ (γc) chain of the interleukin (IL)-2, IL-4, IL-7, IL-9, and IL-15 receptors. Homozygous mutant mice in which the Jak3 gene had been disrupted were generated by gene targeting. Jak3-deficient mice had profound reductions in thymocytes and severe B cell and T cell lymphopenia similar to severe combined immunodeficiency disease (SCID), and the residual T cells and B cells were functionally deficient. Thus, Jak3 plays a critical role in γc signaling and lymphoid development.Keywords
This publication has 22 references indexed in Scilit:
- Mutation of Jak3 in a Patient with SCID: Essential Role of Jak3 in Lymphoid DevelopmentScience, 1995
- Cytokine receptor signallingNature, 1995
- Lymphopenia in interleukin (IL)-7 gene-deleted mice identifies IL-7 as a nonredundant cytokine.The Journal of Experimental Medicine, 1995
- Defective lymphoid development in mice lacking expression of the common cytokine receptor γ chainImmunity, 1995
- Functional Activation of Jak1 and Jak3 by Selective Association with IL-2 Receptor SubunitsScience, 1994
- Early lymphocyte expansion is severely impaired in interleukin 7 receptor-deficient mice.The Journal of Experimental Medicine, 1994
- Involvement of the Jak-3 Janus kinase in signalling by interleukins 2 and 4 in lymphoid and myeloid cellsNature, 1994
- Phosphorylation and activation of the Jak-3 Janus kinase in response to interleukin-2Nature, 1994
- JAK2 associates with the erythropoietin receptor and is tyrosine phosphorylated and activated following stimulation with erythropoietinCell, 1993
- The Primary ImmunodeficienciesNew England Journal of Medicine, 1984